leisure time -WSS

leisure time

author：focus 2025-09-03 09:18:48 - browse：6

Warning sign illustration made of 0s and 1s. -- first opinion coverage from sTAT — Adobe

Big businesses poised to profit from the advance of artificial intelligence in health care are pushing back against newly proposed federal rules meant to increase oversight and fairness of AI tools used to help make decisions about patient care.

The opposition, which includes Google and Amazon as well as large health care providers, insurers, and medical software vendors, is focused on an attempt to put tighter guardrails around the use of AI by the Office of the National Coordinator for Health Information Technology.

The agency wants to require developers of electronic health records and other health software to provide users with details about the training and testing of predictive models that draw data from their systems, or are hosted within them. It also wants developers to assess and publicly disclose potential risks and create a way for clinicians and other users to report problems.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： BIO to announce reorganization, senior leaders expected to depart

WSS

Congress must give Medicare recipients genetic counseling access

Vaccine critic Robert F. Kennedy Jr. says he'll chair Trump vaccine panel

Brain technologies pose threats that are all too real, experts warn

AltruBio raises $225 million to develop ulcerative colitis drug

Hilary may become 1st tropical storm to make landfall in California in 84 years

Empower primary care with adequate payments and technology

focus

leisure time

focus

How to save PrEP access — and even expand it

Empower primary care with adequate payments and technology

Sports medicine is finally prioritizing gender equality

Chemotherapy before breast cancer surgery might fuel metastasis

Wildfire smoke exposes gaps in outdoor worker protections

Ukraine taking heavy casualties 10 weeks into its counteroffensive

As demand for Covid shots wanes, Moderna seeks its next success

AltruBio raises $225 million to develop ulcerative colitis drug

Medical leaders decry Supreme Court decision on affirmative action

Empower primary care with adequate payments and technology

explore

Brain MRIs reveal impact of 'toxic stress' on Black children

Cancer drug shortages' outsize impact on ovarian cancer patients

The creative science of coining drug names

Vaccine critic Robert F. Kennedy Jr. says he'll chair Trump vaccine panel

The creative science of coining drug names

Patient advocates sound warning on FDA proposal on salt intake

leisure time

explore

focus

hotspot